highli
pathogen
avian
influenza
hpai
virus
result
poultri
occasion
human
mortal
first
instanc
human
hpai
viru
infect
occur
hong
kong
reemerg
trigger
sporad
human
infect
asia
middl
east
europ
africa
mortal
rate
could
high
true
mortal
rate
infect
individu
current
unknown
human
infect
close
contact
infect
poultri
viru
mutat
identifi
case
crosshuman
transmiss
recent
report
indic
involv
ha
amino
acid
substitut
lead
easier
transmiss
ferret
suggest
hpai
virus
potenti
evolv
transmit
mammal
thu
pose
risk
human
pandem
accordingli
effect
vaccin
urgent
need
reduc
pandem
potenti
ha
major
envelop
protein
account
approxim
spike
influenza
virion
often
use
major
antigen
subunit
vaccin
develop
neutral
antibodi
elicit
mice
chicken
ferret
use
recombin
ha
protein
express
mammalian
insect
cell
plant
cell
e
coli
cell
recombin
ha
protein
mammalian
insect
cell
capabl
authent
posttransl
modif
eg
disulfid
bond
format
complex
type
glycosyl
facilit
protein
fold
stabil
complex
nlink
ha
glycoprotein
express
mammalian
cell
describ
elicit
stronger
immun
respons
compar
paucimannos
nglycan
express
insect
cell
least
two
research
team
report
singl
glcnac
glycan
complex
nlink
ha
glycoprotein
increas
receptor
bind
sialic
acid
neutral
antibodi
titer
mice
investig
immunogen
ha
bear
differ
nglycan
creat
four
recombin
ha
protein
use
one
mammalian
cho
two
insect
mimic
cell
line
without
neuraminidas
na
treatment
result
show
recombin
ha
protein
carri
paucimannos
highmannos
glycan
elicit
higher
titer
haspecif
igg
antibodi
stronger
cell
respons
compar
recombin
ha
protein
carri
complextyp
glycan
recombin
ha
protein
carri
tri
tetraantennari
complextyp
glycan
induc
even
higher
neutral
hemagglutinininhibit
hi
antibodi
titer
thu
enhanc
protect
immun
result
highli
relev
issu
consid
product
fragment
vaccin
protein
structur
paucimannos
complextyp
nglycan
attach
trimer
influenza
ha
protein
creat
use
crystal
structur
ha
strain
pdb
id
glyprot
structur
clearli
elabor
differ
insect
cell
express
ha
figur
mammalian
cell
express
ha
figur
insect
cell
express
solubl
recombin
haexpress
code
sequenc
clone
pfastbac
vector
obtain
recombin
baculovirus
infect
mimic
cell
cho
cell
mammalian
express
ha
code
sequenc
optim
clone
pisid
express
vector
contain
intron
splice
iresdriven
dhfr
gene
amplif
perform
describ
lin
et
al
recombin
ha
protein
obtain
cultur
supernat
mimic
cho
cell
purifi
use
nickelchel
affin
chromatographi
result
coomassi
blue
stain
sdspage
gel
antibodi
indic
recombin
ha
protein
cell
lower
molecular
weight
ha
protein
mimic
cell
mimicrha
recombin
ha
protein
cho
cell
chorha
highest
molecular
weight
figur
b
purifi
recombin
protein
mimicrha
chorha
obtain
nickelchel
affin
chromatographi
shown
coomassi
blue
stain
figur
although
purifi
ha
protein
clearli
major
compon
final
prepar
host
cell
contamin
ie
dna
microbi
endotoxin
contamin
also
present
labscal
purif
equip
procedur
howev
level
dna
endotoxin
rel
minor
affect
immun
respons
studi
detect
lowlevel
endotoxin
purifi
recombin
ha
protein
sinc
cultur
insect
mammalian
cell
use
ha
express
data
shown
mimic
ha
structur
vivo
viral
neuraminidas
na
activ
chorha
protein
treat
excess
bacteri
na
chorha
na
remov
termin
sialic
acid
figur
demonstr
remov
termin
sialic
acid
decreas
molecular
weight
chorha
vs
chorha
na
confirm
chang
molecular
weight
reflect
differ
glycan
form
recombin
ha
protein
treat
endo
h
pngase
f
hightolow
order
molecular
weight
follow
treatment
endo
h
chorha
chorha
na
mimicrha
figur
sinc
endo
h
cleav
mannosetermin
nglycan
molecular
weight
shift
observ
chorha
chorha
na
figur
vs
figur
b
contrast
four
recombin
ha
protein
approxim
equal
molecular
weight
follow
treatment
pngase
f
figur
result
confirm
differ
nlink
glycan
ad
ha
glycoprotein
via
insect
mammalian
cell
express
sinc
similar
molecular
weight
observ
chorha
pngase
f
treatment
figur
alpha
fucos
first
glcnac
resist
pngase
f
major
glycan
structur
howev
alpha
fucos
exist
chorha
sinc
cho
cell
introduc
alpha
nglycan
mimicrha
chorha
nlink
glycan
pattern
analyz
use
hydrophil
interact
liquid
chromatographi
highperform
liquid
chromatographi
hilichplc
perform
analyz
glycoform
recombin
human
recombin
human
erythropoietin
primarili
contain
paucimannos
highmannos
glycan
along
much
smaller
amount
hybrid
glycan
figur
mimicrha
primarili
contain
biantennari
complex
glycan
without
termin
sialic
acid
along
highmannos
hybrid
minor
paucimannos
glycan
figur
sinc
mimic
cell
deriv
cell
integr
mammalian
glycosyltransferas
mimicrha
mostli
contain
highmannos
complex
glycan
biantennari
structur
figur
sialyl
observ
triantennari
structur
extend
rha
mimic
cell
chorha
mostli
contain
complex
glycan
bi
tri
tetraantennari
structur
contain
one
termin
sialic
acid
figur
chorha
na
glycan
pattern
consist
complex
nglycan
bi
tri
tetraantennari
structur
termin
galactos
end
due
sialic
acidassoci
na
cleavag
mimicrha
chorha
chorha
na
contain
partial
mannosetermin
glycan
could
cleav
endoh
confirm
molecular
weight
shift
sdspage
clearli
observ
endo
h
treatment
figur
group
balbc
mice
mice
per
group
immun
threeweek
interv
two
dose
mimicrha
chorha
chorha
na
protein
contain
pelccpg
adjuv
investig
immun
respons
elicit
recombin
ha
protein
coupl
pelccpg
adjuv
although
unlik
nonadjuv
recombi
ha
protein
elicit
detect
neutral
antibodi
respons
still
conclud
antigen
glycoform
may
elicit
differ
b
cell
respons
without
adjuv
antisera
collect
wk
follow
second
inocul
total
antiha
igg
antibodi
titer
measur
use
elisa
figur
chorha
figur
result
indic
immun
elicit
highest
antiha
total
igg
titer
chorha
immun
lowest
among
four
group
investig
antibodi
avid
strength
total
bond
interact
antibodi
antigen
avid
elisa
quantit
test
determin
strength
antibodi
antigen
low
avid
antibodi
elut
urea
mild
protein
denatur
agent
treatment
ratio
deriv
compar
antibodi
titer
presenc
absenc
urea
high
avid
antibodi
higher
ratio
low
avid
antibodi
confirm
differ
measur
antiha
igg
antibodi
avid
titer
use
urea
elisa
plate
coat
figur
chorha
figur
result
indic
highest
avid
chorha
lowest
among
four
group
investig
confirm
affin
matur
level
trigger
differ
glycan
ha
protein
measur
rel
level
igm
iga
igg
subtyp
sera
immun
mimicrha
chorha
chorha
na
use
elisa
coat
figur
chorha
figur
mimicrha
immun
elicit
slightli
higher
level
igm
compar
chorha
chorha
na
immun
signific
differ
found
serum
iga
level
howev
differ
profil
emerg
distribut
chorha
chorha
na
immun
result
higher
titer
compar
mimicrha
immun
elisa
plate
coat
chorha
immun
elicit
higher
level
compar
mimicrha
chorha
chorha
na
immun
elisa
plate
coat
chorha
accordingli
ha
contain
paucimannos
type
nglycan
induc
higher
level
subtyp
contrast
ha
contain
complex
type
nglycan
chorha
chorha
na
elicit
higher
subtyp
antibodi
splenocyt
collect
group
mice
wk
follow
second
inocul
react
figur
chorha
figur
examin
use
elispot
assay
measur
quantiti
haspecif
antibodysecret
b
cell
spleen
number
elicit
significantli
higher
three
immun
group
larger
foci
found
antibodysecret
b
cell
detect
compar
detect
chorha
four
immun
group
splenocyt
collect
group
mice
wk
follow
second
inocul
stimul
peptid
pool
test
use
elispot
assay
determin
quantiti
cell
result
indic
hightolow
order
cell
four
immun
group
mimicrha
chorha
na
chorha
figur
cell
signific
differ
observ
among
four
immun
group
figur
cell
recognit
antigen
must
present
surfac
dendrit
dc
antigenpres
cell
examin
effect
mimicrha
chorha
chorha
na
antigen
present
treat
bone
marrowderiv
dc
lp
h
follow
incub
four
group
rha
h
cocultur
splenocyt
obtain
mice
immun
bone
marrowderiv
dc
puls
result
strongest
present
stimul
cell
follow
dc
puls
mimicrha
chorha
figur
chorha
stimul
slightli
restor
remov
termin
sialic
acid
chorha
na
higher
level
cell
also
observ
dc
puls
compar
three
group
figur
parallel
studi
use
anim
immun
mimicrha
chorha
chorha
na
react
dc
puls
differ
construct
also
show
result
strongest
present
stimul
cell
indic
cell
respond
best
dc
puls
matter
ha
molecul
mice
immun
figur
combin
result
indic
correl
stronger
cell
respons
elicit
immun
increas
antigenpres
dc
neutral
assay
perform
neutral
antibodi
titer
antisera
collect
four
immun
group
homolog
clade
viru
result
indic
serum
dilutiondepend
neutral
curv
four
group
correspond
valu
chorha
immun
group
approxim
one
log
higher
valu
mimicrha
group
figur
immun
via
remov
termin
sialic
acid
complex
type
nglycan
result
lower
statist
insignific
valu
figur
hi
antibodi
titer
clade
viru
determin
use
influenza
vlp
react
turkey
red
blood
cell
result
indic
hi
titer
chorha
chorha
na
immun
group
also
approxim
one
log
higher
mimicrha
group
figur
sinc
reemerg
virus
mani
new
clade
subclad
evolv
variou
glycosyl
pattern
consist
six
highli
conserv
glycosyl
site
six
divers
glycosyl
site
viru
strain
first
human
isol
fatal
case
thailand
belong
clade
clade
virus
isol
china
vietnam
contain
conserv
glycosyl
site
ha
domin
virus
clade
show
loss
glycosyl
ha
well
virus
clade
thu
crossclad
neutral
antibodi
titer
also
determin
two
heterolog
clade
clade
clade
neutral
titer
chorha
chorha
na
immun
group
also
significantli
higher
obtain
mimicrha
group
case
anhui
figur
hubei
figur
use
challeng
live
virus
assess
protect
immun
mice
four
immun
group
wk
follow
second
inocul
dosag
ha
protein
surviv
rate
figur
reduc
bodi
weight
loss
figur
follow
hightolow
order
chorha
na
chorha
mimicrha
immun
mice
ha
express
cho
cell
without
na
treatment
protect
day
follow
live
viru
challeng
immun
mice
ha
express
insect
cell
protect
reduc
bodi
weight
loss
data
indic
ha
express
cho
cell
result
less
bodi
weight
loss
compar
ha
express
insect
cell
develop
subunit
vaccin
protect
immun
correl
titer
hi
neutral
highqual
antibodi
rather
antigenbind
antibodi
accord
present
result
recombin
ha
glycoprotein
contain
complex
termin
sialyl
asialyatedgalactos
type
nglycan
induc
higher
level
hi
neutral
antibodi
better
protect
immun
mice
compar
recombin
ha
glycoprotein
contain
paucimannos
highmannos
type
nglycan
antibodi
titer
higher
insect
cell
deriv
ha
protein
neutral
titer
much
higher
mammalian
cell
produc
ha
protein
complex
type
nlink
glycan
antibodi
protect
mice
lethal
challeng
result
highli
relev
issu
consid
product
fragment
vaccin
find
chorha
induc
higher
hi
neutral
antibodi
titer
consist
studi
involv
recombin
ha
express
cell
chorha
contain
bi
tri
tetraantennari
complex
type
nglycan
termin
sialic
acid
wherea
mainli
consist
paucimannos
highmannos
type
nglycan
recent
report
recombin
ha
protein
carri
termin
mannos
residu
induc
lower
hi
antibodi
titer
ha
protein
carri
complex
glycan
singl
glcnac
unit
find
present
studi
somewhat
contradictori
much
recombin
ha
protein
carri
low
high
mannos
glycan
elicit
higher
titer
haspecif
antibodi
stronger
cell
respons
inde
higher
glycan
content
tri
tetraantennari
complex
glycan
greater
neutral
hi
titer
consequ
protect
effect
therefor
increas
hi
neutral
antibodi
titer
associ
chorha
due
suppress
dc
activ
termin
mannos
moieti
ha
glycoprotein
report
influenza
ha
instead
found
induc
highest
level
haspecif
total
igg
avid
three
four
igg
subtyp
well
higher
level
cell
increas
dc
antigen
present
effici
although
purifi
protein
mimicrha
chorha
ident
amino
acid
sequenc
antigen
present
effici
antigen
significantli
differ
figur
figur
known
intracellular
antigen
uptak
rout
present
associ
distinct
endocyt
receptor
ctype
lectin
increas
antigen
present
effici
may
mannosetermin
nglycan
interact
lectin
receptor
guid
earli
endosom
compart
still
requir
investig
chorha
chorha
na
display
lower
ratio
compar
mimicrha
versu
respect
suggest
skew
respons
favor
recombin
ha
protein
contain
sialic
acidtermin
galactosetermin
complex
type
nglycan
chorha
induc
higher
neutral
hi
antibodi
titer
total
antibodi
titer
indic
higher
glycan
form
choderiv
recombin
ha
protein
improv
function
antibodi
titer
correl
total
antibodi
titer
although
chorha
induc
higher
antibodi
titer
neutral
antibodi
titer
evid
confirm
correl
increas
antibodi
titer
increas
neutral
antibodi
titer
studi
glycan
pattern
topolog
shield
influenza
ha
molecul
affect
receptor
bind
sialic
acid
greater
sialic
acid
bind
report
follow
trim
modif
oligosaccharid
nglycan
singl
glcnac
paucimannos
highmannos
remov
termin
sialic
acid
complex
type
nglycan
increas
sialic
acid
bind
result
fetuin
bind
assay
mimicrha
chorha
chorha
na
indic
hightolow
bind
activ
order
mimicrha
chorha
na
chorha
figur
sinc
fetuin
contain
sialic
acid
use
array
analyz
recombin
ha
protein
result
indic
bind
sialic
acid
sialic
acid
figur
mimicrha
reduc
bind
sialic
acid
approxim
bind
observ
sialic
acid
rel
low
bind
found
chorha
chorha
na
sialic
acid
compar
strong
bind
bind
intens
chorha
sialic
acid
decreas
almost
fold
compar
howev
chorha
na
increas
bind
sialic
acid
approxim
fold
contrast
immun
chorha
elicit
higher
level
hi
neutral
antibodi
better
protect
immun
challeng
live
virus
result
conflict
recent
descript
singl
glcnac
ha
nglycan
increas
receptor
bind
sialic
acid
well
correl
increas
increas
neutral
antibodi
titer
protect
immun
mice
accordingli
recombin
ha
protein
antigen
immunogen
may
directli
associ
receptor
bind
activ
sialic
acid
result
indic
remov
termin
sialic
acid
bi
tri
tetraantennari
ha
complextyp
nglycan
improv
protect
immun
determin
reduct
bodi
weight
loss
chorha
na
figur
enhanc
protect
immun
provid
remov
sialic
acid
neuraminidas
also
due
chorha
protein
degrad
induc
treatment
requir
confirm
also
found
termin
sialic
acid
complextyp
ha
glycoprotein
significantli
affect
neutral
antibodi
titer
homolog
heterolog
viru
clade
figur
induc
higher
level
cell
increas
dcassoci
antigen
present
effici
figur
report
recombin
ha
protein
cell
show
neutral
antibodi
respons
depend
termin
sialyat
nglycan
increas
dc
bind
report
follow
remov
termin
sialic
acid
therefor
improv
protect
immun
galactosetermin
complex
nglycan
may
also
due
increas
interact
dc
separ
studi
ha
nglycan
influenza
viru
produc
mdck
vero
cell
asialy
former
contain
larger
tri
tetraantennari
alpha
betagalactosetermin
nglycan
latter
contain
smaller
exclus
betagalactosetermin
nglycan
mdck
cellderiv
virus
nglycan
pattern
found
favor
antibodi
respons
vero
cellderiv
influenza
virus
nglycan
pattern
describ
increas
differenti
cell
respons
mediat
dc
present
studi
immun
mimicrha
primarili
contain
galactosetermin
biantennari
highmannos
type
complex
nglycan
yield
lower
level
protect
immun
decreas
bodi
weight
loss
figur
suggest
tri
tetraantennari
complextyp
nglycan
requir
induc
protect
immun
viru
infect
strongli
suggest
recombin
ha
glycoprotein
tri
tetraantennari
complex
type
nglycan
obtain
engin
cho
cell
potenti
use
subunit
vaccin
develop
sinc
ferret
regard
appropri
anim
model
pathogenesi
therapeut
prophylact
develop
differ
similar
mous
ferret
human
immun
respons
project
test
recombin
ha
vaccin
requir
investig
anim
studi
conduct
accord
guidelin
establish
laboratori
anim
center
nation
tsing
hua
univers
nthu
anim
use
protocol
review
approv
nthu
institut
anim
care
use
committe
approv
mous
challeng
experi
evalu
approv
institut
anim
care
use
committe
academia
sinica
solubl
recombin
haexpress
code
sequenc
three
cell
line
includ
ha
ectodomain
strain
follow
termer
motif
tag
describ
lin
et
al
cell
atcc
grown
serumfre
medium
invitrogen
densiti
cellsml
infect
recombin
baculovirus
produc
bactobac
express
system
invitrogen
mimic
cell
invitrogen
grown
medium
supplement
fb
infect
recombin
baculovirus
postinfect
supernat
collect
ha
purif
use
nickelchel
affin
chromatographi
tosoh
vector
express
ha
protein
modifi
pisid
vector
follow
transfect
chodhfr
cell
atcc
select
use
without
rnsdrn
supplement
dialyz
fb
zeocin
invitrogen
highproduc
stabl
cho
cell
clone
select
screen
transfect
stabl
clone
cell
stepwis
increas
mtx
sigma
concentr
cultur
supernat
amplifi
cell
clone
collect
chorha
protein
purif
describ
chorha
na
prepar
purifi
chorha
incub
excess
neuraminidas
vibrio
cholera
mumg
rha
h
ensur
complet
cleavag
recombin
protein
chorha
chorha
na
purifi
use
nickelchel
affin
chromatographi
purifi
recombin
ha
protein
place
sdspage
gel
correspond
band
cut
gel
nlink
glycan
protein
releas
follow
protocol
describ
previous
briefli
cut
gel
frozen
h
slice
piec
piec
wash
twice
mm
ph
wash
discard
replac
acetonitril
mm
incub
min
gel
piec
complet
dri
deglycosyl
pngase
f
roch
overnight
glycan
isol
protein
backbon
use
kda
mwco
filter
dri
speedvac
centrifug
label
remov
excess
hilichplc
altern
hplc
polar
compound
separ
use
separ
individu
glycan
structur
label
glycan
sampl
expos
exoglycosidas
enzym
sialidas
galactosidas
hexosaminidas
fucosidas
prozym
cleav
specif
sugar
molecul
prior
anoth
round
hilichplc
dextran
ladder
gener
hilichplc
use
standard
obtain
glucos
unit
gu
valu
individu
peak
recogn
glycan
rha
antigen
elut
time
obtain
differ
glycan
peak
convert
gu
comparison
elut
fraction
dextran
ladder
report
previous
femal
balbc
mice
wk
old
five
mice
per
group
immun
recombin
ha
protein
mix
pelc
cpg
intramuscular
inject
given
week
blood
collect
week
spleen
collect
splenocyt
isol
second
bleed
individu
well
plate
coat
recombin
ha
protein
express
cho
cell
block
bsa
antibodi
isotyp
subclass
detect
elisa
use
goat
antimous
igm
iga
igg
bethyl
laboratori
inc
avid
elisa
assay
plate
incub
serum
sampl
h
prior
addit
urea
anoth
incub
min
follow
wash
describ
previous
endpoint
titer
calcul
dilut
serum
concentr
give
optic
densiti
read
neg
control
igg
avid
calcul
end
point
titer
ureaend
point
titer
without
urea
x
splenocyt
isol
spleen
remov
mous
mash
cell
strainer
releas
cell
cell
spun
resuspend
ml
ack
lysi
buffer
invitrogen
min
rt
cell
spun
dead
cell
mass
supernat
remov
splenocyt
cell
resuspend
use
experi
bone
marrow
cell
isol
femur
tibia
seed
plate
ml
supplement
medium
fb
mm
lglutamin
nonessenti
amino
acid
sodium
pyruv
hepe
invitrogen
mm
sigmaaldrich
ngml
recombin
mous
gmcsf
invitrogen
day
ml
medium
contain
ngml
gmcsf
ad
half
cellfre
supernat
exchang
fresh
medium
contain
ngml
gmcsf
day
bone
marrowderiv
dc
cell
use
experi
multiscreen
filtrat
plate
millipor
coat
recombin
ha
express
cho
cell
block
fetal
bovin
serum
rpmi
freshli
prepar
splenocyt
ad
well
cellswel
incub
detect
perform
elispot
use
hrpconjug
antimous
igg
antibodi
aec
stain
kit
sigma
spot
count
perform
use
cellular
technolog
immunospot
elispot
reader
cell
determin
elispot
assay
use
readysetgo
kit
ebiosci
follow
manufactur
instruct
antimous
antibodi
use
coat
multiscreen
filtrat
plate
block
fetal
bovin
serum
rpmi
freshli
prepar
splenocyt
ad
well
cellswel
stimul
pool
peptid
overlap
amino
acid
span
aviet
plate
incub
spot
develop
count
conduct
describ
dendrit
cell
dc
deriv
bone
marrow
matur
lp
h
load
recombin
ha
protein
h
follow
wash
cell
fix
paraformaldehyd
min
follow
quench
glycin
min
next
treat
cell
cellsml
coincub
splenocyt
cellsml
collect
mice
immun
mimicrha
chorha
chorha
na
antigen
present
determin
measur
cell
use
readysetgo
kit
ebiosci
describ
sera
treat
receptordestroy
enzym
denka
seiken
h
follow
addit
treatment
min
treat
sera
serial
dilut
twofold
start
incub
ha
unit
vlp
previous
report
min
room
temperatur
next
turkey
rbc
ad
prior
anoth
incub
min
room
temperatur
hi
titer
determin
reciproc
highest
dilut
complet
inhibit
hemagglutin
cell
invitrogen
cotransfect
express
clade
clade
clade
strain
express
na
aviet
strain
cultur
supernat
collect
concentr
h
posttransfect
neutral
antibodi
quantifi
reduc
luciferas
express
level
follow
transduct
mdck
cell
describ
previous
briefli
neutral
antibodi
quantifi
reduc
luciferas
express
level
follow
transduct
mdck
cell
incub
twofold
serial
dilut
antisera
start
dilut
h
prior
addit
mdck
cell
cellswel
cultur
medium
remov
postinfect
cell
lyse
use
glo
lysi
buffer
promega
luciferas
activ
measur
addit
neolit
luciferas
substrat
perkinelm
neutral
titer
repres
serum
dilut
requir
obtain
reduct
rlu
compar
control
well
viru
alon
balbc
mice
wk
old
five
mice
per
group
inocul
two
dose
recombin
ha
vaccin
pbsimmun
mice
use
mock
control
investig
protect
immun
immun
mice
intranas
challeng
lethal
dose
reassort
influenza
viru
wk
follow
second
immun
mous
surviv
rate
weight
loss
monitor
daili
accord
iacuc
guidelin
bodi
weight
loss
use
endpoint
plate
coat
fetuin
overnight
block
bsa
pb
buffer
follow
wash
three
time
tween
buffer
serial
dilut
rha
protein
precomplex
hrpconjug
antihi
tag
antibodi
bethyl
laboratori
inc
min
ad
individu
plate
incub
min
room
temperatur
three
wash
ha
bind
detect
use
elisa
nm
od
microarray
print
biodot
cartesian
technolog
robot
pin
telechem
intern
deposit
nl
variou
concentr
aminecontain
glycan
print
buffer
mm
phosphat
buffer
tween
ph
plate
onto
nhscoat
glass
slide
nexterionhslid
schott
north
america
slide
spot
glycan
solut
design
hold
grid
print
slide
allow
react
humid
h
follow
overnight
desicc
storag
desicc
room
temperatur
use
bind
assay
perform
slide
block
mm
ethanolamin
borat
buffer
ph
wash
twice
water
pb
buffer
ph
recombin
ha
protein
dissolv
wash
buffer
tween
buffer
ph
ad
cover
glycan
array
grid
coverslip
incub
humidifi
chamber
h
slide
wash
three
time
wash
buffer
next
rabbit
ha
antibodi
ad
slide
follow
anoth
h
incub
humidifi
chamber
anoth
three
wash
goat
antirabbit
igg
antibodi
ad
slide
follow
incub
humidifi
chamber
h
slide
wash
three
time
wash
buffer
pb
buffer
dri
slide
scan
nm
microarray
fluoresc
chip
reader
genepix
pro
molecular
devic
result
analyz
use
twotail
student
test
oneway
anova
tukey
test
statist
signific
p
experi
perform
least
twice
similar
result
